Literature DB >> 1422982

Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells.

K Notoya1, K Yoshida, S Taketomi, I Yamazaki, M Kumegawa.   

Abstract

Effects of ipriflavone (7-isopropoxyisoflavone) on osteoclast-induced bone resorption were evaluated using an unfractionated bone cell culture system containing mature osteoclasts from the femur and tibia of newborn mice. When cells were cultured for 4 days on dentin slices in the presence of 5% fetal bovine serum and 10(-8) M 1 alpha, 25(OH)2D3, ipriflavone (3 x 10(-7) -3 x 10(-5) M) inhibited pit formation and caused a decrease in the number of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells (MNCs). The lowest significant effect was observed at a concentration of 10(-6) M. Unlike ipriflavone, calcitonin inhibited pit formation 4 days after the culture was started without affecting the number of TRAP-positive MNCs. Ipriflavone still inhibited pit formation when the culture period was 13 days, when new osteoclasts were expected to be formed. These findings suggest that ipriflavone inhibits new osteoclast formation and bone resorption at the cellular level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422982     DOI: 10.1007/bf02180241

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  13 in total

1.  Periosteal osteoclasts, skeletal development and ageing.

Authors:  E A TONNA
Journal:  Nature       Date:  1960-02-06       Impact factor: 49.962

2.  Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats.

Authors:  E Bonucci; P Ballanti; A Martelli; E Mereto; G Brambilla; P Bianco; L Bufalino
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

3.  Acute reduction in osteoclast number during bone repletion.

Authors:  C C Liu; J I Rader; H Gruber; D J Baylink
Journal:  Metab Bone Dis Relat Res       Date:  1982

4.  A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells.

Authors:  Y Takada; M Kusuda; K Hiura; T Sato; H Mochizuki; Y Nagao; M Tomura; M Yahiro; Y Hakeda; H Kawashima
Journal:  Bone Miner       Date:  1992-06

5.  Disposition of ipriflavone (TC-80) in rats and dogs.

Authors:  K Yoshida; T Tsukamoto; H Torii; T Doi; I Naeshiro; K Shibata; I Uemura; S Tanayama
Journal:  Radioisotopes       Date:  1985-11

6.  The effect of ipriflavone (TC-80) on bone resorption in tissue culture.

Authors:  M Tsuda; T Kitazaki; T Ito; T Fujita
Journal:  J Bone Miner Res       Date:  1986-04       Impact factor: 6.741

7.  The effect of ipriflavone treatment on osteoporosis induced by immobilization.

Authors:  I Földes; M Rapcsák; A Szöör; J Gyarmati; T Szilágyi
Journal:  Acta Morphol Hung       Date:  1988

8.  Calcitonin secreting property of ipriflavone in the presence of estrogen.

Authors:  I Yamazaki; M Kinoshita
Journal:  Life Sci       Date:  1986-04-28       Impact factor: 5.037

9.  Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats.

Authors:  I Yamazaki; A Shino; Y Shimizu; R Tsukuda; Y Shirakawa; M Kinoshita
Journal:  Life Sci       Date:  1986-03-10       Impact factor: 5.037

10.  Effect of ipriflavone on bone changes induced by calcium restricted, vitamin D deficient diet in rats.

Authors:  M Takenaka; M Nakata; M Tomita; T Nakagawa; S Tsuboi; M Fukase; T Fujita
Journal:  Endocrinol Jpn       Date:  1986-02
View more
  6 in total

1.  Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.

Authors:  K Notoya; S Taketomi; M Tsuda
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

2.  Ipriflavone improves bone density and biomechanical properties of adult male rat bones.

Authors:  R Civitelli; S H Abbasi-Jarhomi; L R Halstead; A Dimarogonas
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

3.  Interactions between ipriflavone and the estrogen receptor.

Authors:  M Petilli; G Fiorelli; S Benvenuti; U Frediani; F Gori; M L Brandi
Journal:  Calcif Tissue Int       Date:  1995-02       Impact factor: 4.333

4.  Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass.

Authors:  M Valente; L Bufalino; G N Castiglione; R D'Angelo; A Mancuso; P Galoppi; L Zichella
Journal:  Calcif Tissue Int       Date:  1994-05       Impact factor: 4.333

5.  Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.

Authors:  K Notoya; K Yoshida; S Taketomi; I Yamazaki; M Kumegawa
Journal:  Calcif Tissue Int       Date:  1993-09       Impact factor: 4.333

6.  Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites.

Authors:  S L Cheng; S F Zhang; T L Nelson; P M Warlow; R Civitelli
Journal:  Calcif Tissue Int       Date:  1994-11       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.